Clinical Trials Browser

Phase 3 × Recruiting × Disease × Clear all

NCT06713837 2026-04-08

IMPACT-AML

Phase 3 Recruiting

Other hematologic neoplasm

Disease, Recurrence, Leukemia, Myeloid, Acute